Skip to main navigation
ArriVent Biopharma logo
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Investor Contact
ArriVent Biopharma image

SEC Filing Details

Financial Information
  • SEC Filings

Document Details

Form
424B5
Filing Date
May 11, 2026
Document Date
May 11, 2026
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
ArriVent Biopharma
Issuer
ARRIVENT BIOPHARMA, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
XML - XBRL INSTANCE DOCUMENT
drafts jallaire@lifesciadvisors.com
©2026 ArriVent Biopharma, Inc. All rights reserved.
ARRIVENT and  Reg. U.S. Pat. & Tm. Off.
Search Investors